Follow us...

 

Search News Archives

News Channels

 

New Laboratory Products

Lab News

What's going on at Lab Innovations

Research & Case Studies

Microscopy | Image Analysis

Separation Science

Brochures & Literature

Videos

Events | Webinars

 

 

Conferences | Events

New Co-ordinated Technical and Legal Services for Pharma and Biotech Companies

publication date: Apr 19, 2010
 | 
author/source: b3c newswire

MLawGroup and WS Partners Management Consulting (WS Partners) are pleased to offer new co-ordinated advisory services to pharma and biotech companies. Both firms are specialized in advising pharma and biotech companies on legal and technical issues respectively. As part of their co-operation and as a new service to their clients in the industry, they now offer the comprehensive preparation of agreements and the performance of due diligence reviews prior to the conclusion of such agreements which take into account both technical and legal aspects.

The main focus of the co-operation of both advisory firms is the preparation and negotiation of agreements  in the areas of licensing, collaboration, partnering, CMO, CRO, M&A and equity financing rounds, as well as the performance of due diligence reviews preceding such agreements in the pharma and biotech sector.

It is often possible to improve the quality of advice and moreover to save costs and time if the external technical and legal experts involved in these projects do not, as is usually the case, advise their clients independently of each other, but rather co-ordinate their advisory services. The timely inclusion of technical, regulatory, legal and strategic aspects as part of a comprehensive preparation of agreements and performance of due diligence reviews based on co-ordinated project management avoids loss of information, misunderstandings, duplication of work, delays and unnecessary costs.

The idea of offering co-ordinated technical and legal services came about when Dr. Werner Stüber of WS Partners und Dr. Henning Mennenöh of MLawGroup found themselves repeatedly advising clients in the pharma and biotech sector on the same projects. Joining forces in this way seemed logical, and many clients showed great interest in the idea. WS Partners and MLawGroup then decided to intensify their co-operation and to offer to pharma and biotech clients a co-ordinated preparation of agreements and performance of due diligence reviews covering both technical and legal issues.  „Our co-operation will allow clients to achieve clear quality, cost and time advantages", agree Dr. Werner Stüber and Dr. Henning Mennenöh.    

About WS Partners Management Consulting (WS Partners) - www.ws-partners.com
WS Partners is an internationally active consulting company located in Lahntal, Germany with a focus on biotech, pharma and chemistry. We advise our clients in the following areas:

  • Drug Development (Project Management, CMC and Pre-Clinical)
  • Production (CMO Management, GMP)
  • Business Development
  • Assessments / Due Diligence
  • Patent Issues

We work with national and international clients of all sizes, from start-up companies to listed companies.


 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd

 


Promotions

 

Media Partners